Longeveron Inc. (LGVN)

Latest Insider Confidence Score

2026Q1

39.2
Bearish

Company insider confidence (by quarter)

2021Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Ds Med Llc — 7,024,208 Apr 15, 2022
Hare Joshua Chief Scientific Officer 721,796 May 16, 2025
Lehr Paul T General Counsel, Secretary 351,129 Oct 3, 2025
Locklear Lisa CFO 239,081 Oct 3, 2025
Agafonova Nataliya Chief Medical Officer 226,814 Oct 3, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 2, 2026 Jan 6, 2026 Agafonova Nataliya Chief Medical Officer Sell 27.5 -10,250 -4.52% ✗ $6.1K
Jan 2, 2026 Jan 6, 2026 Lehr Paul T General Counsel, Secretary Sell 27.5 -6,952 -1.98% ✗ $4.1K
Jan 2, 2026 Jan 6, 2026 Locklear Lisa CFO Sell 27.5 -10,250 -4.29% ✗ $6.1K
Jan 2, 2026 Jan 6, 2026 Blass Devin CTO & SVP of CMC Sell 27.5 -10,700 -5.07% ✗ $6.3K
Jan 2, 2026 Jan 6, 2026 Powell James Nathaniel CEO Sell 27.5 -2,464 -1.92% ✗ $1.5K
Oct 1, 2025 Oct 27, 2025 Paletta George A. Jr. Director Neutral 90.0 +34,000 100.00% ✗ -
Oct 27, 2025 Paletta George A. Jr. Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 3, 2025 Agafonova Nataliya Chief Medical Officer Sell 27.5 -11,883 -4.98% ✗ $8.8K
Oct 1, 2025 Oct 3, 2025 Powell James Nathaniel CEO Sell 27.5 -2,389 -1.83% ✗ $1.8K
Oct 1, 2025 Oct 3, 2025 Lehr Paul T General Counsel, Secretary Sell 27.5 -4,944 -1.39% ✗ $3.7K
Oct 1, 2025 Oct 3, 2025 Blass Devin CTO & SVP of CMC Sell 27.5 -7,609 -3.48% ✗ $5.6K
Oct 1, 2025 Oct 3, 2025 Locklear Lisa CFO Sell 27.5 -11,883 -4.73% ✗ $8.8K
Sep 4, 2025 Oct 1, 2025 Powell James Nathaniel CEO Neutral 90.0 +50,000 62.15% ✗ -
Oct 1, 2025 Powell James Nathaniel CEO Neutral 52.5 - 0.00% ✗ -
Aug 11, 2025 Aug 13, 2025 Locklear Lisa CFO Neutral 82.5 +11,766 4.92% ✗ -
Aug 11, 2025 Aug 13, 2025 Baluch Khoso Director Neutral 90.0 +11,766 28.87% ✗ -
Jul 15, 2025 Jul 17, 2025 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jul 15, 2025 Jul 17, 2025 Soffer Rock Director Neutral 85.0 +17,000 8.13% ✗ -
Jul 15, 2025 Jul 17, 2025 Agafonova Nataliya Chief Medical Officer Neutral 90.0 +102,000 74.62% ✗ -
Jul 15, 2025 Jul 17, 2025 Hajjar Roger Joseph Director Neutral 90.0 +17,000 106.25% ✗ -
Jul 15, 2025 Jul 17, 2025 Lehr Paul T General Counsel, Secretary Neutral 90.0 +102,000 40.15% ✗ -
Jul 15, 2025 Jul 17, 2025 Locklear Lisa CFO Neutral 90.0 +102,000 74.35% ✗ -
Jul 15, 2025 Jul 17, 2025 Blass Devin CTO & SVP of CMC Neutral 90.0 +102,000 87.56% ✗ -
Jul 15, 2025 Jul 17, 2025 Baluch Khoso Director Neutral 90.0 +17,000 71.58% ✗ -
Jul 15, 2025 Jul 17, 2025 Hashad Mohamed Wa'el Ahmed CEO Neutral 90.0 +180,000 74.72% ✗ -
Jul 15, 2025 Jul 17, 2025 Kender Richard N Director Neutral 90.0 +17,000 106.25% ✗ -
Jul 15, 2025 Jul 17, 2025 Motwani Neha J. Director Neutral 90.0 +17,000 106.25% ✗ -
Jul 15, 2025 Jul 17, 2025 Ungaro Ursula Director Neutral 90.0 +17,000 70.83% ✗ -
Jul 1, 2025 Jul 3, 2025 Blass Devin CTO & SVP of CMC Sell 27.5 -4,599 -3.80% ✗ $5.9K
Jul 1, 2025 Jul 3, 2025 Hashad Mohamed Wa'el Ahmed CEO Sell 26.3 -13,146 -5.17% ✗ $16.8K
Jul 1, 2025 Jul 3, 2025 Locklear Lisa CFO Sell 27.5 -7,431 -5.14% ✗ $9.5K
Jul 1, 2025 Jul 3, 2025 Lehr Paul T General Counsel, Secretary Sell 37.5 -1,562 -0.61% ✗ $2K
Jul 1, 2025 Jul 3, 2025 Agafonova Nataliya Chief Medical Officer Sell 27.5 -7,431 -5.16% ✗ $9.5K
Jul 1, 2025 Jul 3, 2025 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Lehr Paul T General Counsel, Secretary Sell 95.0 +98,885 63.08% ✗ $73.8K
Jun 13, 2025 Jun 17, 2025 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 17, 2025 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
May 29, 2025 Jun 2, 2025 Soffer Rock Director Sell 26.3 -21,000 -9.13% ✗ $26.8K
May 22, 2025 May 27, 2025 Soffer Rock Director Sell 37.5 -2,000 -0.86% ✗ $2.6K
May 16, 2025 May 16, 2025 Hare Joshua Chief Scientific Officer Sell 37.5 -5,250 -0.72% ✗ $7.4K
Apr 21, 2025 Blass Devin CTO & SVP of CMC Neutral 52.5 - 0.00% ✗ -
Apr 1, 2025 Apr 3, 2025 Agafonova Nataliya Chief Medical Officer Sell 26.3 -7,566 -4.99% ✗ $11.3K
Apr 1, 2025 Apr 3, 2025 Locklear Lisa CFO Sell 26.3 -7,566 -4.97% ✗ $11.3K
Apr 1, 2025 Apr 3, 2025 Hashad Mohamed Wa'el Ahmed CEO Sell 26.3 -13,384 -5.00% ✗ $20.1K
Apr 1, 2025 Apr 3, 2025 Lehr Paul T General Counsel, Secretary Sell 27.5 -1,599 -1.01% ✗ $2.4K
Mar 4, 2025 Mar 6, 2025 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Agafonova Nataliya Chief Medical Officer Sell 26.3 -6,120 -3.88% ✗ $11K
Jan 2, 2025 Jan 6, 2025 Hashad Mohamed Wa'el Ahmed CEO Sell 26.3 -10,827 -3.89% ✗ $19.4K
Jan 2, 2025 Jan 6, 2025 Locklear Lisa CFO Sell 26.3 -6,120 -3.87% ✗ $11K
Jan 2, 2025 Jan 6, 2025 Lehr Paul T General Counsel, Secretary Sell 37.5 -1,205 -0.76% ✗ $2.2K
Dec 2, 2024 Dec 4, 2024 Baluch Khoso Director Sell 27.5 -1,250 -5.00% ✗ $2.6K
Oct 1, 2024 Oct 3, 2024 Locklear Lisa CFO Sell 27.5 -5,316 -3.25% ✗ $10K
Oct 1, 2024 Oct 3, 2024 Agafonova Nataliya Chief Medical Officer Sell 27.5 -5,316 -3.26% ✗ $10K
Oct 1, 2024 Oct 3, 2024 Lehr Paul T General Counsel, Secretary Sell 37.5 -990 -0.62% ✗ $1.9K
Oct 1, 2024 Oct 3, 2024 Hashad Mohamed Wa'el Ahmed CEO Sell 26.3 -13,357 -4.58% ✗ $25.1K
Aug 15, 2024 Aug 19, 2024 Agafonova Nataliya Chief Medical Officer Sell 91.3 +161,359 9111.18% ✗ $35.4K
Aug 15, 2024 Aug 19, 2024 Locklear Lisa CFO Sell 91.3 +160,715 5511.49% ✗ $34.5K
Aug 15, 2024 Aug 19, 2024 Hashad Mohamed Wa'el Ahmed CEO Sell 95.0 +272,002 182.27% ✗ $96.6K
Aug 15, 2024 Aug 19, 2024 Lehr Paul T General Counsel, Secretary Sell 95.0 +146,628 103.20% ✗ $77.5K
Aug 15, 2024 Aug 19, 2024 Hare Joshua Chief Scientific Officer Neutral 90.0 +93,766 14.81% ✗ -
Aug 15, 2024 Aug 19, 2024 Baluch Khoso Director Neutral 90.0 +23,500 157.98% ✗ -
Aug 15, 2024 Aug 19, 2024 Ungaro Ursula Director Neutral 90.0 +23,500 4700.00% ✗ -
Aug 15, 2024 Aug 19, 2024 Soffer Rock Director Neutral 90.0 +23,500 11.27% ✗ -
Aug 15, 2024 Aug 19, 2024 Hare Neil E Director Neutral 90.0 +23,500 348.35% ✗ -
Aug 7, 2024 Motwani Neha J. Director Neutral 52.5 - 0.00% ✗ -
Aug 7, 2024 Hajjar Roger Joseph Director Neutral 52.5 - 0.00% ✗ -
Jul 2, 2024 Aug 7, 2024 Hajjar Roger Joseph Director Neutral 90.0 +16,000 100.00% ✗ -
Jul 2, 2024 Aug 7, 2024 Motwani Neha J. Director Neutral 90.0 +16,000 100.00% ✗ -
Jul 1, 2024 Jul 3, 2024 Locklear Lisa CFO Sell 27.5 -357 -10.91% ✗ $560.5
Jun 9, 2024 Jun 11, 2024 Baluch Khoso Director Sell 37.5 -125 -0.83% ✗ $132.5
Jun 3, 2024 Jun 7, 2024 Lehr Paul T General Counsel, Secretary Sell 45.0 -325 -0.23% ✗ $338
May 10, 2024 May 14, 2024 Kender Richard N Director Neutral 90.0 +16,000 100.00% ✗ -
May 14, 2024 Kender Richard N Director Neutral 52.5 - 0.00% ✗ -
May 2, 2024 May 6, 2024 Locklear Lisa CFO Sell 27.5 -410 -11.13% ✗ $1.2K
May 2, 2024 May 6, 2024 Agafonova Nataliya Chief Medical Officer Sell 27.5 -308 -14.81% ✗ $871.6
Apr 10, 2024 Apr 12, 2024 Hare Joshua Chief Scientific Officer Buy 97.5 +148,936 30.75% ✗ $350K
Apr 11, 2024 Apr 12, 2024 Hashad Mohamed Wa'el Ahmed CEO Buy 91.3 +10,638 118.49% ✗ $25K
Apr 10, 2024 Apr 12, 2024 Soffer Rock Director Buy 97.5 +138,298 196.90% ✗ $325K
Mar 12, 2024 Mar 20, 2024 Hashad Mohamed Wa'el Ahmed CEO Sell 91.3 +47,334 111.52% ✗ $17.7K
Mar 1, 2023 Feb 2, 2024 Hashad Mohamed Wa'el Ahmed CEO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 25, 2024 Locklear Lisa CFO Sell 27.5 -4,098 -10.01% ✗ $5.4K
Jan 2, 2024 Jan 25, 2024 Hashad Mohamed Wa'el Ahmed CEO Sell 27.5 -5,123 -10.77% ✗ $6.8K
Jan 2, 2024 Jan 25, 2024 Lehr Paul T General Counsel, Secretary Sell 37.5 -992 -0.69% ✗ $1.3K
Jan 2, 2024 Jan 25, 2024 Agafonova Nataliya Chief Medical Officer Sell 27.5 -3,074 -12.88% ✗ $4.1K
Jan 10, 2024 Jan 11, 2024 Ross Cathy Director Buy 90.0 +5,000 100.00% ✗ $6.5K
Dec 28, 2023 Jan 2, 2024 Baluch Khoso Director Buy 91.3 +10,000 200.00% ✗ $14.3K
Dec 28, 2023 Dec 29, 2023 PFEFFER JEFFREY Director Buy 91.3 +10,000 200.00% ✗ $13.5K
Dec 21, 2023 Dec 26, 2023 LOSORDO DOUGLAS W Director Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 Soffer Rock Director Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 Ungaro Ursula Director Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 Ross Cathy Director Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 Hare Neil E Director Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 Baluch Khoso Director Neutral 52.5 - 0.00% ✗ -
Dec 21, 2023 Dec 26, 2023 PFEFFER JEFFREY Director Neutral 52.5 - 0.00% ✗ -
Oct 2, 2023 Oct 4, 2023 Lehr Paul T General Counsel, Secretary Sell 37.5 -815 -0.57% ✗ $1.9K
Oct 2, 2023 Oct 4, 2023 Locklear Lisa CFO Sell 27.5 -4,078 -9.06% ✗ $9.3K
Oct 2, 2023 Oct 4, 2023 Agafonova Nataliya Chief Medical Officer Sell 27.5 -3,059 -11.36% ✗ $7K
Sep 21, 2023 Sep 22, 2023 Hare Joshua Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Sep 20, 2023 Sep 21, 2023 Lehr Paul T General Counsel, Secretary Neutral 52.5 - 0.00% ✗ -